TOKYO -- An eyedrop drug that researchers in Japan believe could stop myopia from becoming worse is set to enter clinical trials in a potential boon for the billions of sufferers worldwide.
Pharmaceuticals
Myopia eyedrops headed for clinical trials in Japan
Drug hoped to slow nearsightedness affecting 2bn people worldwide
Myopia is skyrocketing in children, an increase attributed to the spread of smartphones and tablets. (Photo by Kotaro Fukuoka)
Read Next
.jpg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
Latest on Pharmaceuticals
